0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Glucagon Like Peptide 2 Receptor Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-16E7234
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Glucagon Like Peptide 2 Receptor Market Insights Forecast to 2028
BUY CHAPTERS

Global Glucagon Like Peptide 2 Receptor Market Research Report 2025

Code: QYRE-Auto-16E7234
Report
September 2025
Pages:67
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Glucagon Like Peptide 2 Receptor Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Glucagon Like Peptide 2 Receptor Market

Glucagon Like Peptide 2 Receptor Market

The global market for Glucagon Like Peptide 2 Receptor was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Glucagon Like Peptide 2 Receptor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glucagon Like Peptide 2 Receptor.
The Glucagon Like Peptide 2 Receptor market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Glucagon Like Peptide 2 Receptor market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glucagon Like Peptide 2 Receptor manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Glucagon Like Peptide 2 Receptor Market Report

Report Metric Details
Report Name Glucagon Like Peptide 2 Receptor Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
  • FE-203799
  • Glepaglutide
  • GXG-8
  • HM-15910
  • Others
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Hanmi Pharmaceuticals Co Ltd, Naia Ltd, Takeda, Tasly Pharmaceutical Group Co Ltd, Zealand Pharma AS
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Glucagon Like Peptide 2 Receptor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Glucagon Like Peptide 2 Receptor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Glucagon Like Peptide 2 Receptor Market report?

Ans: The main players in the Glucagon Like Peptide 2 Receptor Market are Hanmi Pharmaceuticals Co Ltd, Naia Ltd, Takeda, Tasly Pharmaceutical Group Co Ltd, Zealand Pharma AS

What are the Application segmentation covered in the Glucagon Like Peptide 2 Receptor Market report?

Ans: The Applications covered in the Glucagon Like Peptide 2 Receptor Market report are Short Bowel Syndrome, Diabetes, Diarrhea, Obesity, Others

What are the Type segmentation covered in the Glucagon Like Peptide 2 Receptor Market report?

Ans: The Types covered in the Glucagon Like Peptide 2 Receptor Market report are FE-203799, Glepaglutide, GXG-8, HM-15910, Others

Recommended Reports

Diabetes Devices

Diabetes Therapeutics

Peptide Receptor Markets

1 Glucagon Like Peptide 2 Receptor Market Overview
1.1 Product Definition
1.2 Glucagon Like Peptide 2 Receptor by Type
1.2.1 Global Glucagon Like Peptide 2 Receptor Market Value Comparison by Type (2024 VS 2031)
1.2.2 FE-203799
1.2.3 Glepaglutide
1.2.4 GXG-8
1.2.5 HM-15910
1.2.6 Others
1.3 Glucagon Like Peptide 2 Receptor by Application
1.3.1 Global Glucagon Like Peptide 2 Receptor Market Value by Application (2024 VS 2031)
1.3.2 Short Bowel Syndrome
1.3.3 Diabetes
1.3.4 Diarrhea
1.3.5 Obesity
1.3.6 Others
1.4 Global Glucagon Like Peptide 2 Receptor Market Size Estimates and Forecasts
1.4.1 Global Glucagon Like Peptide 2 Receptor Revenue 2020-2031
1.4.2 Global Glucagon Like Peptide 2 Receptor Sales 2020-2031
1.4.3 Global Glucagon Like Peptide 2 Receptor Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Glucagon Like Peptide 2 Receptor Market Competition by Manufacturers
2.1 Global Glucagon Like Peptide 2 Receptor Sales Market Share by Manufacturers (2020-2025)
2.2 Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Glucagon Like Peptide 2 Receptor Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Glucagon Like Peptide 2 Receptor, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Glucagon Like Peptide 2 Receptor, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Glucagon Like Peptide 2 Receptor, Product Type & Application
2.7 Global Key Manufacturers of Glucagon Like Peptide 2 Receptor, Date of Enter into This Industry
2.8 Global Glucagon Like Peptide 2 Receptor Market Competitive Situation and Trends
2.8.1 Global Glucagon Like Peptide 2 Receptor Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Glucagon Like Peptide 2 Receptor Players Market Share by Revenue
2.8.3 Global Glucagon Like Peptide 2 Receptor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Glucagon Like Peptide 2 Receptor Market Scenario by Region
3.1 Global Glucagon Like Peptide 2 Receptor Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Glucagon Like Peptide 2 Receptor Sales by Region: 2020-2031
3.2.1 Global Glucagon Like Peptide 2 Receptor Sales by Region: 2020-2025
3.2.2 Global Glucagon Like Peptide 2 Receptor Sales by Region: 2026-2031
3.3 Global Glucagon Like Peptide 2 Receptor Revenue by Region: 2020-2031
3.3.1 Global Glucagon Like Peptide 2 Receptor Revenue by Region: 2020-2025
3.3.2 Global Glucagon Like Peptide 2 Receptor Revenue by Region: 2026-2031
3.4 North America Glucagon Like Peptide 2 Receptor Market Facts & Figures by Country
3.4.1 North America Glucagon Like Peptide 2 Receptor Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Glucagon Like Peptide 2 Receptor Sales by Country (2020-2031)
3.4.3 North America Glucagon Like Peptide 2 Receptor Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Glucagon Like Peptide 2 Receptor Market Facts & Figures by Country
3.5.1 Europe Glucagon Like Peptide 2 Receptor Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Glucagon Like Peptide 2 Receptor Sales by Country (2020-2031)
3.5.3 Europe Glucagon Like Peptide 2 Receptor Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Glucagon Like Peptide 2 Receptor Market Facts & Figures by Region
3.6.1 Asia Pacific Glucagon Like Peptide 2 Receptor Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Glucagon Like Peptide 2 Receptor Sales by Region (2020-2031)
3.6.3 Asia Pacific Glucagon Like Peptide 2 Receptor Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Glucagon Like Peptide 2 Receptor Market Facts & Figures by Country
3.7.1 Latin America Glucagon Like Peptide 2 Receptor Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Glucagon Like Peptide 2 Receptor Sales by Country (2020-2031)
3.7.3 Latin America Glucagon Like Peptide 2 Receptor Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Glucagon Like Peptide 2 Receptor Market Facts & Figures by Country
3.8.1 Middle East and Africa Glucagon Like Peptide 2 Receptor Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Glucagon Like Peptide 2 Receptor Sales by Country (2020-2031)
3.8.3 Middle East and Africa Glucagon Like Peptide 2 Receptor Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Glucagon Like Peptide 2 Receptor Sales by Type (2020-2031)
4.1.1 Global Glucagon Like Peptide 2 Receptor Sales by Type (2020-2025)
4.1.2 Global Glucagon Like Peptide 2 Receptor Sales by Type (2026-2031)
4.1.3 Global Glucagon Like Peptide 2 Receptor Sales Market Share by Type (2020-2031)
4.2 Global Glucagon Like Peptide 2 Receptor Revenue by Type (2020-2031)
4.2.1 Global Glucagon Like Peptide 2 Receptor Revenue by Type (2020-2025)
4.2.2 Global Glucagon Like Peptide 2 Receptor Revenue by Type (2026-2031)
4.2.3 Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Type (2020-2031)
4.3 Global Glucagon Like Peptide 2 Receptor Price by Type (2020-2031)
5 Segment by Application
5.1 Global Glucagon Like Peptide 2 Receptor Sales by Application (2020-2031)
5.1.1 Global Glucagon Like Peptide 2 Receptor Sales by Application (2020-2025)
5.1.2 Global Glucagon Like Peptide 2 Receptor Sales by Application (2026-2031)
5.1.3 Global Glucagon Like Peptide 2 Receptor Sales Market Share by Application (2020-2031)
5.2 Global Glucagon Like Peptide 2 Receptor Revenue by Application (2020-2031)
5.2.1 Global Glucagon Like Peptide 2 Receptor Revenue by Application (2020-2025)
5.2.2 Global Glucagon Like Peptide 2 Receptor Revenue by Application (2026-2031)
5.2.3 Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Application (2020-2031)
5.3 Global Glucagon Like Peptide 2 Receptor Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Hanmi Pharmaceuticals Co Ltd
6.1.1 Hanmi Pharmaceuticals Co Ltd Company Information
6.1.2 Hanmi Pharmaceuticals Co Ltd Description and Business Overview
6.1.3 Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Product Portfolio
6.1.5 Hanmi Pharmaceuticals Co Ltd Recent Developments/Updates
6.2 Naia Ltd
6.2.1 Naia Ltd Company Information
6.2.2 Naia Ltd Description and Business Overview
6.2.3 Naia Ltd Glucagon Like Peptide 2 Receptor Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Naia Ltd Glucagon Like Peptide 2 Receptor Product Portfolio
6.2.5 Naia Ltd Recent Developments/Updates
6.3 Takeda
6.3.1 Takeda Company Information
6.3.2 Takeda Description and Business Overview
6.3.3 Takeda Glucagon Like Peptide 2 Receptor Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Takeda Glucagon Like Peptide 2 Receptor Product Portfolio
6.3.5 Takeda Recent Developments/Updates
6.4 Tasly Pharmaceutical Group Co Ltd
6.4.1 Tasly Pharmaceutical Group Co Ltd Company Information
6.4.2 Tasly Pharmaceutical Group Co Ltd Description and Business Overview
6.4.3 Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Product Portfolio
6.4.5 Tasly Pharmaceutical Group Co Ltd Recent Developments/Updates
6.5 Zealand Pharma AS
6.5.1 Zealand Pharma AS Company Information
6.5.2 Zealand Pharma AS Description and Business Overview
6.5.3 Zealand Pharma AS Glucagon Like Peptide 2 Receptor Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Zealand Pharma AS Glucagon Like Peptide 2 Receptor Product Portfolio
6.5.5 Zealand Pharma AS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Glucagon Like Peptide 2 Receptor Industry Chain Analysis
7.2 Glucagon Like Peptide 2 Receptor Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Glucagon Like Peptide 2 Receptor Production Mode & Process Analysis
7.4 Glucagon Like Peptide 2 Receptor Sales and Marketing
7.4.1 Glucagon Like Peptide 2 Receptor Sales Channels
7.4.2 Glucagon Like Peptide 2 Receptor Distributors
7.5 Glucagon Like Peptide 2 Receptor Customer Analysis
8 Glucagon Like Peptide 2 Receptor Market Dynamics
8.1 Glucagon Like Peptide 2 Receptor Industry Trends
8.2 Glucagon Like Peptide 2 Receptor Market Drivers
8.3 Glucagon Like Peptide 2 Receptor Market Challenges
8.4 Glucagon Like Peptide 2 Receptor Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Glucagon Like Peptide 2 Receptor Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Glucagon Like Peptide 2 Receptor Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Glucagon Like Peptide 2 Receptor Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Glucagon Like Peptide 2 Receptor Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Glucagon Like Peptide 2 Receptor Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Glucagon Like Peptide 2 Receptor Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Glucagon Like Peptide 2 Receptor Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Glucagon Like Peptide 2 Receptor, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Glucagon Like Peptide 2 Receptor, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Glucagon Like Peptide 2 Receptor, Product Type & Application
 Table 12. Global Key Manufacturers of Glucagon Like Peptide 2 Receptor, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Glucagon Like Peptide 2 Receptor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glucagon Like Peptide 2 Receptor as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Glucagon Like Peptide 2 Receptor Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Glucagon Like Peptide 2 Receptor Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Region (2020-2025)
 Table 19. Global Glucagon Like Peptide 2 Receptor Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Region (2026-2031)
 Table 21. Global Glucagon Like Peptide 2 Receptor Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Region (2020-2025)
 Table 23. Global Glucagon Like Peptide 2 Receptor Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Region (2026-2031)
 Table 25. North America Glucagon Like Peptide 2 Receptor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Glucagon Like Peptide 2 Receptor Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Glucagon Like Peptide 2 Receptor Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Glucagon Like Peptide 2 Receptor Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Glucagon Like Peptide 2 Receptor Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Glucagon Like Peptide 2 Receptor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Glucagon Like Peptide 2 Receptor Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Glucagon Like Peptide 2 Receptor Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Glucagon Like Peptide 2 Receptor Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Glucagon Like Peptide 2 Receptor Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Glucagon Like Peptide 2 Receptor Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Glucagon Like Peptide 2 Receptor Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Glucagon Like Peptide 2 Receptor Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Glucagon Like Peptide 2 Receptor Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Glucagon Like Peptide 2 Receptor Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Glucagon Like Peptide 2 Receptor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Glucagon Like Peptide 2 Receptor Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Glucagon Like Peptide 2 Receptor Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Glucagon Like Peptide 2 Receptor Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Glucagon Like Peptide 2 Receptor Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Glucagon Like Peptide 2 Receptor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Glucagon Like Peptide 2 Receptor Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Glucagon Like Peptide 2 Receptor Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Glucagon Like Peptide 2 Receptor Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Glucagon Like Peptide 2 Receptor Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Type (2020-2025)
 Table 53. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Type (2026-2031)
 Table 54. Global Glucagon Like Peptide 2 Receptor Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Glucagon Like Peptide 2 Receptor Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Type (2020-2025)
 Table 57. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Type (2026-2031)
 Table 58. Global Glucagon Like Peptide 2 Receptor Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Glucagon Like Peptide 2 Receptor Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Glucagon Like Peptide 2 Receptor Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Glucagon Like Peptide 2 Receptor Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Application (2020-2025)
 Table 63. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Application (2026-2031)
 Table 64. Global Glucagon Like Peptide 2 Receptor Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Glucagon Like Peptide 2 Receptor Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Application (2020-2025)
 Table 67. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Application (2026-2031)
 Table 68. Global Glucagon Like Peptide 2 Receptor Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Glucagon Like Peptide 2 Receptor Price (USD/Pcs) by Application (2026-2031)
 Table 70. Hanmi Pharmaceuticals Co Ltd Company Information
 Table 71. Hanmi Pharmaceuticals Co Ltd Description and Business Overview
 Table 72. Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Product
 Table 74. Hanmi Pharmaceuticals Co Ltd Recent Developments/Updates
 Table 75. Naia Ltd Company Information
 Table 76. Naia Ltd Description and Business Overview
 Table 77. Naia Ltd Glucagon Like Peptide 2 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Naia Ltd Glucagon Like Peptide 2 Receptor Product
 Table 79. Naia Ltd Recent Developments/Updates
 Table 80. Takeda Company Information
 Table 81. Takeda Description and Business Overview
 Table 82. Takeda Glucagon Like Peptide 2 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Takeda Glucagon Like Peptide 2 Receptor Product
 Table 84. Takeda Recent Developments/Updates
 Table 85. Tasly Pharmaceutical Group Co Ltd Company Information
 Table 86. Tasly Pharmaceutical Group Co Ltd Description and Business Overview
 Table 87. Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Product
 Table 89. Tasly Pharmaceutical Group Co Ltd Recent Developments/Updates
 Table 90. Zealand Pharma AS Company Information
 Table 91. Zealand Pharma AS Description and Business Overview
 Table 92. Zealand Pharma AS Glucagon Like Peptide 2 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Zealand Pharma AS Glucagon Like Peptide 2 Receptor Product
 Table 94. Zealand Pharma AS Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Glucagon Like Peptide 2 Receptor Distributors List
 Table 98. Glucagon Like Peptide 2 Receptor Customers List
 Table 99. Glucagon Like Peptide 2 Receptor Market Trends
 Table 100. Glucagon Like Peptide 2 Receptor Market Drivers
 Table 101. Glucagon Like Peptide 2 Receptor Market Challenges
 Table 102. Glucagon Like Peptide 2 Receptor Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Glucagon Like Peptide 2 Receptor
 Figure 2. Global Glucagon Like Peptide 2 Receptor Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Glucagon Like Peptide 2 Receptor Market Share by Type: 2024 & 2031
 Figure 4. FE-203799 Product Picture
 Figure 5. Glepaglutide Product Picture
 Figure 6. GXG-8 Product Picture
 Figure 7. HM-15910 Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Glucagon Like Peptide 2 Receptor Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Glucagon Like Peptide 2 Receptor Market Share by Application: 2024 & 2031
 Figure 11. Short Bowel Syndrome
 Figure 12. Diabetes
 Figure 13. Diarrhea
 Figure 14. Obesity
 Figure 15. Others
 Figure 16. Global Glucagon Like Peptide 2 Receptor Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Glucagon Like Peptide 2 Receptor Market Size (2020-2031) & (US$ Million)
 Figure 18. Global Glucagon Like Peptide 2 Receptor Sales (2020-2031) & (K Pcs)
 Figure 19. Global Glucagon Like Peptide 2 Receptor Average Price (USD/Pcs) & (2020-2031)
 Figure 20. Glucagon Like Peptide 2 Receptor Report Years Considered
 Figure 21. Glucagon Like Peptide 2 Receptor Sales Share by Manufacturers in 2024
 Figure 22. Global Glucagon Like Peptide 2 Receptor Revenue Share by Manufacturers in 2024
 Figure 23. Global 5 and 10 Largest Glucagon Like Peptide 2 Receptor Players: Market Share by Revenue in Glucagon Like Peptide 2 Receptor in 2024
 Figure 24. Glucagon Like Peptide 2 Receptor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 25. Global Glucagon Like Peptide 2 Receptor Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 26. North America Glucagon Like Peptide 2 Receptor Sales Market Share by Country (2020-2031)
 Figure 27. North America Glucagon Like Peptide 2 Receptor Revenue Market Share by Country (2020-2031)
 Figure 28. U.S. Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Canada Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Europe Glucagon Like Peptide 2 Receptor Sales Market Share by Country (2020-2031)
 Figure 31. Europe Glucagon Like Peptide 2 Receptor Revenue Market Share by Country (2020-2031)
 Figure 32. Germany Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. France Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. U.K. Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Italy Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Russia Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Asia Pacific Glucagon Like Peptide 2 Receptor Sales Market Share by Region (2020-2031)
 Figure 38. Asia Pacific Glucagon Like Peptide 2 Receptor Revenue Market Share by Region (2020-2031)
 Figure 39. China Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Japan Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. South Korea Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. India Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Australia Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Taiwan Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Indonesia Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Thailand Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Malaysia Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Philippines Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Latin America Glucagon Like Peptide 2 Receptor Sales Market Share by Country (2020-2031)
 Figure 50. Latin America Glucagon Like Peptide 2 Receptor Revenue Market Share by Country (2020-2031)
 Figure 51. Mexico Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Brazil Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Argentina Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales Market Share by Country (2020-2031)
 Figure 55. Middle East and Africa Glucagon Like Peptide 2 Receptor Revenue Market Share by Country (2020-2031)
 Figure 56. Turkey Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Saudi Arabia Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. UAE Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Global Sales Market Share of Glucagon Like Peptide 2 Receptor by Type (2020-2031)
 Figure 60. Global Revenue Market Share of Glucagon Like Peptide 2 Receptor by Type (2020-2031)
 Figure 61. Global Glucagon Like Peptide 2 Receptor Price (USD/Pcs) by Type (2020-2031)
 Figure 62. Global Sales Market Share of Glucagon Like Peptide 2 Receptor by Application (2020-2031)
 Figure 63. Global Revenue Market Share of Glucagon Like Peptide 2 Receptor by Application (2020-2031)
 Figure 64. Global Glucagon Like Peptide 2 Receptor Price (USD/Pcs) by Application (2020-2031)
 Figure 65. Glucagon Like Peptide 2 Receptor Value Chain
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS